Published in J Immunol on April 15, 1994
Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol (1995) 1.01
Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis. Clin Exp Immunol (1998) 0.90
Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides. Clin Exp Immunol (2000) 0.87
Human anti-Ro autoantibodies bind multiple conformational epitopes of 60-kD Ro autoantigen. J Clin Immunol (1997) 0.79
The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis. Immunology (1996) 0.79
Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding. Clin Exp Immunol (2006) 0.76
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
RNA recognition: towards identifying determinants of specificity. Trends Biochem Sci (1991) 9.03
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell (2001) 8.04
A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein. Cell (1989) 7.42
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A (2000) 4.99
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol (1993) 4.63
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev (1999) 3.45
Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol Cell Biol (1997) 3.21
Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) (1976) 3.07
Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet (1997) 3.05
Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc Natl Acad Sci U S A (1994) 2.95
RNA-binding domain of the A protein component of the U1 small nuclear ribonucleoprotein analyzed by NMR spectroscopy is structurally similar to ribosomal proteins. Proc Natl Acad Sci U S A (1991) 2.87
ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci (1998) 2.83
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Quantitative determination that one of two potential RNA-binding domains of the A protein component of the U1 small nuclear ribonucleoprotein complex binds with high affinity to stem-loop II of U1 RNA. Proc Natl Acad Sci U S A (1990) 2.76
ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev (1999) 2.65
A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell (1987) 2.58
U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res (1991) 2.49
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem (1988) 2.37
Incomplete Reiter's syndrome: discriminating features and HL-A W27 in diagnosis. Ann Intern Med (1976) 2.34
Recognition of U1 and U2 small nuclear RNAs can be altered by a 5-amino-acid segment in the U2 small nuclear ribonucleoprotein particle (snRNP) B" protein and through interactions with U2 snRNP-A' protein. Mol Cell Biol (1991) 2.33
Hel-N1/Hel-N2 proteins are bound to poly(A)+ mRNA in granular RNP structures and are implicated in neuronal differentiation. J Cell Sci (1996) 2.18
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell (1983) 2.14
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Molecular analysis of the 60-kDa human Ro ribonucleoprotein. Proc Natl Acad Sci U S A (1988) 2.11
Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor. J Neurosci (1994) 2.09
Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A (1985) 2.07
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum (1990) 1.99
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Sequence-specific contacts between the RNA polymerase of vesicular stomatitis virus and the leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.95
Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus. J Cell Sci (1998) 1.94
Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol Cell Biol (1994) 1.94
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
The U1 RNA-binding site of the U1 small nuclear ribonucleoprotein (snRNP)-associated A protein suggests a similarity with U2 snRNPs. Mol Cell Biol (1989) 1.87
Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum (2001) 1.87
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) (2006) 1.77
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J Virol (1984) 1.75
Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet (1986) 1.74
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
Studies in familial systemic lupus erythematosus. Medicine (Baltimore) (1976) 1.70
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
A specific 31-nucleotide domain of U1 RNA directly interacts with the 70K small nuclear ribonucleoprotein component. Mol Cell Biol (1989) 1.68
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) (2007) 1.63
Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem (2000) 1.54
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Vesicular stomatitis virus defective interfering particle containing a muted internal leader RNA gene. Proc Natl Acad Sci U S A (1981) 1.53
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Association between the 7 S RNA and the lupus La protein varies among cell types. J Biol Chem (1983) 1.51
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med (1982) 1.51
In vitro selection of an RNA epitope immunologically cross-reactive with a peptide. Proc Natl Acad Sci U S A (1992) 1.50
A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1983) 1.50
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum (1988) 1.47
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum (1999) 1.45
Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity. J Rheumatol (1993) 1.42
Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene (2008) 1.41
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
Search for organising principles: understanding in systems biology. Syst Biol (Stevenage) (2004) 1.40
Characterization of the 3' terminus of RNA isolated from vesicular stomatitis virus and from its defective interfering particles. Proc Natl Acad Sci U S A (1977) 1.40
Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med (1991) 1.40
Leucine periodicity of U2 small nuclear ribonucleoprotein particle (snRNP) A' protein is implicated in snRNP assembly via protein-protein interactions. Mol Cell Biol (1991) 1.37
Rapid and transient localization of the leader RNA of vesicular stomatitis virus in the nuclei of infected cells. Proc Natl Acad Sci U S A (1982) 1.35
RNA polymerase-associated interactions near template promoter sequences of defective interfering particles of vesicular stomatitis virus. J Virol (1982) 1.34
Incomplete Reiter's syndrome: clinical comparisons with classical triad. Ann Rheum Dis (1979) 1.34
Exploring molecular diversity with combinatorial shape libraries. Trends Biochem Sci (1994) 1.33
Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med (1986) 1.31
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus. Mol Cell Biol (1987) 1.29
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
A sequence-specific conformational epitope on U1 RNA is recognized by a unique autoantibody. Proc Natl Acad Sci U S A (1988) 1.26
Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J Biol Chem (2000) 1.26
Nature of the 3'-terminal sequences of the plus and minus strands of the S1 gene of reovirus serotypes 1, 2 and 3. Virology (1980) 1.22
Overexpression of the arginine-rich carboxy-terminal region of U1 snRNP 70K inhibits both splicing and nucleocytoplasmic transport of mRNA. Genes Dev (1995) 1.21
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. J Immunol (1985) 1.20
Autoantibodies specific for U1 RNA and initiator methionine tRNA. J Biol Chem (1986) 1.15
HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens (1999) 1.14
Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis (1989) 1.14
HL-A 27 in Reiter's syndrome and psoriatic arthritis: a genetic factor in disease susceptibility and expression. J Rheumatol (1984) 1.13
Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med (1990) 1.12
In vitro selection of aptamers from RNA libraries. Methods Mol Biol (1999) 1.12
Base mutations in the terminal noncoding regions of the genome of vesicular stomatitis virus isolated from persistent infections of L cells. Virology (1985) 1.11
Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins. J Clin Invest (1994) 1.11
HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Hum Immunol (1981) 1.11
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol (1991) 1.11
Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol (2001) 1.11
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest (1992) 1.11